Gurrola Sandra M 4
4 · Brooklyn ImmunoTherapeutics, Inc. · Filed Jun 22, 2021
Insider Transaction Report
Form 4
Gurrola Sandra M
VP of Finance
Transactions
- Award
Restricted Stock Unit
2021-06-21+35,000→ 35,000 total→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]The option vests and becomes exercisable in four equal installments on June 21 of each of 2022, 2023, 2024 and 2025, provided they shall vest in full immediately prior to a Change in Control (as defined in Ms. Gurrola's Executive Employment Agreement, dated as of June 16, 2021 and effective as of June 21, 2021), subject to continued service through each vesting date.